CytoDyn Inc.

8-K Regulation FD disclosure Apr 30, 2026 10-Q Quarter ended 2026-02-28 Apr 8, 2026 8-K Entered a material agreement Mar 24, 2026 8-K Unregistered sale of equity Mar 5, 2026 10-Q Quarter ended 2025-11-30 Jan 9, 2026 8-K Other events Dec 1, 2025 8-K Amended charter or bylaws; Shareholder vote results Nov 21, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Nov 3, 2025 10-Q Quarter ended 2025-08-31 Oct 10, 2025 10-K Fiscal year ended 2025-05-31 Jul 25, 2025 8-K Changed accountants May 16, 2025 8-K Director or officer change; Regulation FD disclosure May 6, 2025 10-Q Quarter ended 2025-02-28 Apr 14, 2025 10-Q Quarter ended 2024-11-30 Jan 14, 2025 8-K Shareholder vote results Nov 22, 2024 10-Q Quarter ended 2024-08-31 Oct 15, 2024 10-K/A Fiscal year ended 2024-05-31 Sep 30, 2024 10-K Fiscal year ended 2024-05-31 Aug 15, 2024 8-K Regulation FD disclosure; Other events Jul 9, 2024 8-K Changed accountants Jun 28, 2024 8-K Unregistered sale of equity Jun 3, 2024 8-K Changed accountants May 6, 2024 10-Q Quarter ended 2024-02-29 Apr 15, 2024 8-K Terminated a material agreement Apr 8, 2024 8-K Unregistered sale of equity Mar 28, 2024 8-K Director or officer change; Regulation FD disclosure Jan 29, 2024 10-Q Quarter ended 2023-11-30 Jan 16, 2024 8-K Other events Dec 22, 2023 8-K Other events Dec 14, 2023 8-K Terminated a material agreement Nov 28, 2023 8-K Director or officer change; Regulation FD disclosure Nov 21, 2023 8-K Amended charter or bylaws; Shareholder vote results Nov 9, 2023 8-K Regulation FD disclosure Nov 6, 2023 10-Q Quarter ended 2023-08-31 Oct 23, 2023 8-K Changed accountants Oct 10, 2023 8-K Changed accountants Sep 25, 2023 10-K Fiscal year ended 2023-05-31 Sep 14, 2023 8-K Unregistered sale of equity Aug 17, 2023 8-K Director or officer change; Regulation FD disclosure Jul 11, 2023 8-K Director or officer change; Regulation FD disclosure May 24, 2023